# Pacific Science LLC – FDA 483, May 28, 2026

Source: https://www.keypedia.com/records/483/pacific-science-llc/87f8fd17-bab6-46d8-9777-c36f698eb6c8

> FDA 483 for Pacific Science LLC on May 28, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Pacific Science LLC
- Inspection Date: 2026-05-28
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: Pacific Science LLC, a biorepository stability storage facility in El Segundo, CA, was cited for significant deficiencies related to its quality control unit. The inspection revealed a lack of a written quality agreement with a sponsor for a combination drug/device product, leading to ambiguity in responsibilities for stability sample storage and equipment maintenance. Additionally, the firm could not provide a sponsor-approved stability protocol.

## Related Officers

- [Claudia M. Perez-Kasmarski](https://www.keypedia.com/people/claudia-m-perez-kasmarski/ee989ba2-eb7a-47ae-8be5-7a28f748343b)

Company: https://www.keypedia.com/companies/pacific-science-llc/63ee6edd-1369-439b-83eb-5763f55a7436

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6